Senior Director, Search & Evaluation Late TA Lead, Immunology — CSL Behring

CHF 94'500 - 143'000
CSL Behring · Bern (BE)
Categoria: Sanità Contratto: full-time Salario: CHF 94'500 - 143'000
Apply now
Location
Bern
Contract
full-time
Posted
35 days ago
SalaryCHF 94'500 - 143'000

Role overview

CSL's R&D organization is accelerating innovation to deliver greater impact for patients.

With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems.

Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology?

The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office.

This is a hybrid position and is onsite three days a week.

Position Description Summary ​ Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area.

You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care.

The role is critical to shaping our portfolio through high-impact partnerships and transactions.

​ Main Responsibilities & Accountabilities ​

  • Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning.

Main responsibilities

  • The role is critical to shaping our portfolio through high-impact partnerships and transactions. ​ Main Responsibilities & Accountabilities ​
  • Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. ​
  • Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. ​
  • Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL’s therapeutic areas.
  • NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations ​
  • Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics. ​
  • Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. ​
  • Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. ​
  • Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution ​
  • Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. ​ Qualifications & Experience Requirements ​

Company and context

  • CSL's R&D organization is accelerating innovation to deliver greater impact for patients.
  • With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems.
  • Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.
  • Could you be our next Senior Director Search & Evaluation Late TA Lead, Immunology?
  • The job is in our Waltham MA, King of Prussia PA, Glattburg Switzerland or Maidenhead UK Office.
  • This is a hybrid position and is onsite three days a week.
  • Position Description Summary ​ Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external Hematology therapeutic area.
  • You will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care.
Apply now
Logo CSL Behring
Company
CSL Behring · Bern
Frontaliere Ticino discovered this opportunity through company monitoring.

All CSL Behring jobs in Bern →